Copenhagen’s Aisel Health raises €1.7 million to scale its AI operating system for psychiatric care

According to EU-Startups, homeDenmark-StartupsCopenhagen’s Aisel Health raises €1.7 million to scale its AI operating system… HomeDenmark-StartupsCopenhagen’s Aisel Health raises €1.7 million to scale its AI operating system…Denmark-StartupsFunding Copenhagen’s Aisel Health raises €1.7 million to scale its AI operating system for psychiatric care By Rahul Raj August 19, 2026 Share FacebookTwitterWhatsAppLinkedin Aisel Health, a Copenhagen-based HealthTech company building an operating system (OS) purpose-built for psychiatry and mental health, today announced it has closed a €1.7 million pre-Seed round.  The round was led by Caesar Ventures, with participation from Nordic Web Ventures, LifeX, and Angel Invest, alongside existing investors Rockstart and EIFO.“Psychiatry doesn’t need more generic technology bolted onto an already overburdened workflow.Key players involved: Insight Partners, Goldman Sachs Asset Management This development has significant implications for Technology, potentially influencing competitive dynamics, investment patterns, and strategic priorities across the sector. The company states that it improves the patient experience, reduces strain on staff, and increases clinic profitability. Market ImplicationsForward-Looking IndicatorsContinued consolidation expected in the sectorIncreasing focus on digital transformation and innovationGrowing importance of ESG considerations Expert CommentaryIt needs a product built around the realities of psychiatric care – where clinicians bring judgment, empathy, and years of trained intuition, and the technology brings the speed, structure, and ability to hold together every detail about every patient, in a way no human memory can,” said Augusta Klingsten Peytz, co-founder and CEO of Aisel Health.  Founded in 2024 by Peytz and Christian Houen, Aisel Health builds software that helps psychiatric clinics scale their operations by surfacing the right information for clinicians at the right time. Looking AheadFor complete details on this development, refer to the original report from EU-Startups. Frequently Asked Questions